Astrotech Corporation Reports Revenue Surge to $297,000 in Q1 FY 2025

Astrotech Corporation reported a significant increase in revenue for the first quarter of fiscal year 2025, with total revenue reaching $297,000, compared to $34,000 in the same period last year. This increase of $263,000 was primarily driven by the recognition of grant revenue associated with the completion of milestones in Phases I and II, which contributed $230,000 to total revenue. The company also noted higher revenues from training services and consumables, although warranty revenue decreased by $12,000. Gross profit for the quarter was $188,000, resulting in a gross margin of 63%, a notable improvement from 26% in the prior year.

Operating expenses for the quarter increased to $3.7 million, up from $3.6 million in the previous year, reflecting a rise in selling, general, and administrative expenses, which increased by $92,000. Research and development expenses saw a slight decrease of $5,000. The company reported a net loss of $3.5 million for the quarter, compared to a net loss of $3.3 million in the same period last year. The loss per share was $(2.07), slightly higher than the $(2.01) reported in the prior year.

Astrotech's balance sheet as of September 30, 2025, showed total assets of $23.2 million, down from $27.0 million at the end of the previous fiscal year. Current assets decreased to $18.2 million, primarily due to a reduction in cash and cash equivalents, which fell to $2.6 million from $3.1 million. The company’s total liabilities also decreased to $4.2 million from $4.9 million, reflecting a reduction in accounts payable and lease liabilities. Stockholders' equity declined to $19.1 million from $22.1 million, largely due to the net loss incurred during the quarter.

In terms of strategic developments, Astrotech continues to focus on expanding its product offerings and market presence. The company is commercializing its Astrotech Mass Spectrometer Technology™ through various subsidiaries, including 1st Detect Corporation, which has developed the TRACER 1000™ explosives trace detector. The TRACER 1000 is currently deployed in 34 locations across 16 countries and has received TSA approval for air cargo security applications. Additionally, Astrotech is advancing its AgLAB 1000™ series of mass spectrometers for the hemp and cannabis markets, with ongoing field trials demonstrating improved yields in distillation processes.

Looking ahead, Astrotech remains focused on enhancing its product lines and expanding its market reach. The company is actively pursuing opportunities in both domestic and international markets, particularly in the security and agricultural sectors. However, management acknowledges potential risks, including economic conditions, competition, and regulatory challenges, which could impact future performance. The company expects to continue investing in research and development to drive innovation and improve operational efficiency.